MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00392-019-01541-8

Медицинская библиотека · Clinical research in cardiology : official journal of the German Cardiac Society · 2019

Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis utilizing the next-generation fully retrievable and repositionable valve system: mid-term results from a prospective multicentre registry.

Kochman Janusz, Zbroński Karol, Kołtowski Łukasz, Parma Radosław, Ochała Andrzej, Huczek Zenon, Rymuza Bartosz, Wilimski Radosław, Dąbrowski Maciej, Witkowski Adam, Scisło Piotr, Grygier Marek, Lesiak Maciej, Opolski Grzegorz

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

The aim of this study was to evaluate the outcomes of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BiAV) stenosis using a mechanically expanded Lotus™ device. The prior experience with first-generation devices showed disappointing results mainly due to increased prevalence of aortic regurgitation (AR) that exceeded those observed in tricuspid stenosis.

METHODS AND

RESULTS

We collected baseline, in-hospital, 30-day and 2-year follow-up data from a prospective, multicentre registry of patients with BiAV undergoing TAVI using Lotus™ valve. Safety and efficacy endpoints were assessed according to VARC-2 criteria. The study group comprised 24 patients. The mean age was 73.5 years and the mean EuroSCORE 2 was 4.35 ± 2.56%. MDCT analysis revealed Type 1 BiAV in 75% of patients. The mean gradient decreased from 60.1 ± 18.3 to 15 ± 6.4 mm Hg, the AVA increased from 0.6 ± 0.19 to 1.7 ± 0.21 cm2. One in-hospital death was observed secondary to aortic perforation. There was no severe AR and the rate of moderate AR equalled 9% at 30 days (n = 2). Device success was achieved in 83% and the 30-day safety endpoint was 17%. In the 2-year follow-up, the overall mortality was 12.5% and the 2-year composite clinical efficacy endpoint was met in 25% of the patients (n = 6)

CONCLUSIONS

The TAVI in selected BiAV patients using the Lotus™ is feasible and characterized by encouraging valve performance and mid-term clinical outcomes.

Для цитирования: Kochman Janusz, Zbroński Karol, Kołtowski Łukasz, Parma Radosław, Ochała Andrzej, Huczek Zenon, Rymuza Bartosz, Wilimski Radosław, Dąbrowski Maciej, Witkowski Adam, Scisło Piotr, Grygier Marek, Lesiak Maciej, Opolski Grzegorz. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis utilizing the next-generation fully retrievable and repositionable valve system: mid-term results from a prospective multicentre registry.. Clinical research in cardiology : official journal of the German Cardiac Society. 2019. DOI: 10.1007/s00392-019-01541-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.